NBIO Insider Trading Activity and SEC Form 4 Filings
NBIO insider trading summary
No open-market insider purchases or sales of Nascent Biotech Inc. (NBIO) have been reported on SEC Form 4 in the past 12 months.
Latest NBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 7, 2023 | Lowell Thomas Holden | CFO | Buy | $5K (130,000 @ $0.04) |
| Jan 27, 2023 | Lowell Thomas Holden | CFO | Buy | $3K (20,000 @ $0.14) |
| Jan 27, 2023 | Lowell Thomas Holden | CFO | Buy | $3K (20,000 @ $0.14) |
| Jul 21, 2022 | Lowell Thomas Holden | CFO | Sell | $1K (5,000 @ $0.26) |
| Dec 26, 2019 | Lowell Thomas Holden | CFO | Buy | $825 (5,000 @ $0.17) |
| Oct 3, 2019 | Lowell Thomas Holden | CFO | Buy | $1K (10,000 @ $0.14) |
| Oct 8, 2015 | Sean Carrick | Principal Executive Officer | Buy | $300 (1,500 @ $0.20) |
| Sep 4, 2015 | Lowell Thomas Holden | CFO | Buy | $895K (617,346 @ $1.45) |
| Sep 4, 2015 | Brandon Price | Senior VP Business Development | Buy | $895K (617,346 @ $1.45) |
| Sep 4, 2015 | Sean Carrick | Principal Executive Officer | Buy | $1.5M (1,028,901 @ $1.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.